Found: 87
Select item for more details and to access through your institution.
A non-human primate in vitro functional assay for the early evaluation of TB vaccine candidates.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-020-00263-7
- By:
- Publication type:
- Article
The effect of current Schistosoma mansoni infection on the immunogenicity of a candidate TB vaccine, MVA85A, in BCG-vaccinated adolescents: An open-label trial.
- Published in:
- PLoS Neglected Tropical Diseases, 2017, v. 11, n. 5, p. 1, doi. 10.1371/journal.pntd.0005440
- By:
- Publication type:
- Article
Cross-laboratory evaluation of multiplex bead assays including independent common reference standards for immunological monitoring of observational and interventional human studies.
- Published in:
- PLoS ONE, 2018, v. 13, n. 9, p. 1, doi. 10.1371/journal.pone.0201205
- By:
- Publication type:
- Article
Hepcidin deficiency and iron deficiency do not alter tuberculosis susceptibility in a murine M.tb infection model.
- Published in:
- PLoS ONE, 2018, v. 13, n. 1, p. 1, doi. 10.1371/journal.pone.0191038
- By:
- Publication type:
- Article
Safety and Immunogenicity of Newborn MVA85A Vaccination and Selective, Delayed Bacille Calmette-Guerin for Infants of Human Immunodeficiency Virus-Infected Mothers: A Phase 2 Randomized, Controlled Trial.
- Published in:
- Clinical Infectious Diseases, 2018, v. 66, n. 4, p. 554, doi. 10.1093/cid/cix834
- By:
- Publication type:
- Article
Review of Current Tuberculosis Human Infection Studies for Use in Accelerating Tuberculosis Vaccine Development: A Meeting Report.
- Published in:
- Journal of Infectious Diseases, 2024, v. 230, n. 2, p. e457, doi. 10.1093/infdis/jiae238
- By:
- Publication type:
- Article
Improving Tuberculosis Vaccine Trial Efficiency: A Tough Nut to Crack.
- Published in:
- Journal of Infectious Diseases, 2023, v. 228, n. 9, p. 1147, doi. 10.1093/infdis/jiad360
- By:
- Publication type:
- Article
Rapid research response to the COVID-19 pandemic: perspectives from a National Institute for Health Biomedical Research Centre.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Identification of antigens presented by MHC for vaccines against tuberculosis.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. 1, doi. 10.1038/s41541-019-0148-y
- By:
- Publication type:
- Article
Phase I Trial Evaluating the Safety and Immunogenicity of Candidate TB Vaccine MVA85A, Delivered by Aerosol to Healthy M.tb -Infected Adults.
- Published in:
- Vaccines, 2021, v. 9, n. 4, p. 396, doi. 10.3390/vaccines9040396
- By:
- Publication type:
- Article
Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infection.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-32755-x
- By:
- Publication type:
- Article
Low-dose M.tb infection but not BCG or MTBVAC vaccination enhances heterologous antibody titres in non-human primates.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1387454
- By:
- Publication type:
- Article
Editorial Commentary: Understanding BCG Is the Key to Improving It.
- Published in:
- 2014
- By:
- Publication type:
- Editorial
Enhancing the Biological Relevance of Machine Learning Classifiers for Reverse Vaccinology.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 2, p. 312, doi. 10.3390/ijms18020312
- By:
- Publication type:
- Article
The Humoral Immune Response to BCG Vaccination.
- Published in:
- Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.01317
- By:
- Publication type:
- Article
Elevated IgG Responses in Infants Are Associated With Reduced Prevalence of <italic>Mycobacterium tuberculosis</italic> Infection.
- Published in:
- Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.01529
- By:
- Publication type:
- Article
Aerosol immunisation for TB: matching route of vaccination to route of infection.
- Published in:
- Transactions of the Royal Society of Tropical Medicine & Hygiene, 2015, v. 109, n. 3, p. 175, doi. 10.1093/trstmh/tru206
- By:
- Publication type:
- Article
Mycobacterium tuberculosis PPD-induced immunebiomarkers measurable in vitro following BCGvaccination of UK adolescents by multiplex beadarray and intracellular cytokine staining.
- Published in:
- BMC Immunology, 2010, v. 11, p. 35, doi. 10.1186/1471-2172-11-35
- By:
- Publication type:
- Article
Regulation of mycobacterial infection by macrophage Gch1 and tetrahydrobiopterin.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-07714-9
- By:
- Publication type:
- Article
Replacing, Reducing and Refining the Use of Animals in Tuberculosis Vaccine Research.
- Published in:
- Altex, 2017, v. 34, n. 1, p. 157, doi. 10.14573/altex.1607281
- By:
- Publication type:
- Article
Lessons from the pandemic on the value of research infrastructure.
- Published in:
- 2021
- By:
- Publication type:
- letter
Heterologous vaccination against human tuberculosis modulates antigen-specific CD4<sup>+</sup> T-cell function.
- Published in:
- European Journal of Immunology, 2013, v. 43, n. 9, p. 2409, doi. 10.1002/eji.201343454
- By:
- Publication type:
- Article
Correction: Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4.
- Published in:
- European Journal of Immunology, 2011, v. 41, n. 5, p. 1501, doi. 10.1002/eji.201190032
- By:
- Publication type:
- Article
Correction: Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4.
- Published in:
- European Journal of Immunology, 2011, v. 41, n. 5, p. 1501, doi. 10.1002/eji.201190030
- By:
- Publication type:
- Article
Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4.
- Published in:
- European Journal of Immunology, 2010, v. 40, n. 1, p. 279, doi. 10.1002/eji.200939754
- By:
- Publication type:
- Article
Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4.
- Published in:
- European Journal of Immunology, 2007, v. 37, n. 11, p. 3089, doi. 10.1002/eji.200737504
- By:
- Publication type:
- Article
Tuberculin Skin Testing and Treatment Modulates Interferon-Gamma Release Assay Results for Latent Tuberculosis in Migrants.
- Published in:
- PLoS ONE, 2014, v. 9, n. 5, p. 1, doi. 10.1371/journal.pone.0097366
- By:
- Publication type:
- Article
The Candidate TB Vaccine, MVA85A, Induces Highly Durable Th1 Responses.
- Published in:
- PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0087340
- By:
- Publication type:
- Article
A Multi-Antigenic Adenoviral-Vectored Vaccine Improves BCG-Induced Protection of Goats against Pulmonary Tuberculosis Infection and Prevents Disease Progression.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0081317
- By:
- Publication type:
- Article
Cholera Toxin Enhances Vaccine-Induced Protection against Mycobacterium Tuberculosis Challenge in Mice.
- Published in:
- PLoS ONE, 2013, v. 8, n. 10, p. 1, doi. 10.1371/journal.pone.0078312
- By:
- Publication type:
- Article
Roles for Treg Expansion and HMGB1 Signaling through the TLR1-2-6 Axis in Determining the Magnitude of the Antigen-Specific Immune Response to MVA85A.
- Published in:
- PLoS ONE, 2013, v. 8, n. 7, p. 1, doi. 10.1371/journal.pone.0067922
- By:
- Publication type:
- Article
Two Doses of Candidate TB Vaccine MVA85A in Antiretroviral Therapy (ART) Naïve Subjects Gives Comparable Immunogenicity to One Dose in ART+ Subjects.
- Published in:
- PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0067177
- By:
- Publication type:
- Article
Optimising Immunogenicity with Viral Vectors: Mixing MVA and HAdV-5 Expressing the Mycobacterial Antigen Ag85A in a Single Injection.
- Published in:
- PLoS ONE, 2012, v. 7, n. 12, p. 1, doi. 10.1371/journal.pone.0050447
- By:
- Publication type:
- Article
Identification of Antigens Specific to Non-Tuberculous Mycobacteria: The Mce Family of Proteins as a Target of T Cell Immune Responses.
- Published in:
- PLoS ONE, 2011, v. 6, n. 10, p. 1, doi. 10.1371/journal.pone.0026434
- By:
- Publication type:
- Article
Th1/Th17 Cell Induction and Corresponding Reduction in ATP Consumption following Vaccination with the Novel Mycobacterium tuberculosis Vaccine MVA85A.
- Published in:
- PLoS ONE, 2011, v. 6, n. 8, p. 1, doi. 10.1371/journal.pone.0023463
- By:
- Publication type:
- Article
Dual Neonate Vaccine Platform against HIV-1 and M. tuberculosis.
- Published in:
- PLoS ONE, 2011, v. 6, n. 5, p. 1, doi. 10.1371/journal.pone.0020067
- By:
- Publication type:
- Article
Preclinical Development of an In Vivo BCG Challenge Model for Testing Candidate TB Vaccine Efficacy.
- Published in:
- PLoS ONE, 2011, v. 6, n. 5, p. 1, doi. 10.1371/journal.pone.0019840
- By:
- Publication type:
- Article
The Tuberculin Skin Test (TST) Is Affected by Recent BCG Vaccination but Not by Exposure to Non-Tuberculosis Mycobacteria (NTM) during Early Life.
- Published in:
- PLoS ONE, 2010, v. 5, n. 8, p. 1, doi. 10.1371/journal.pone.0012287
- By:
- Publication type:
- Article
Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A.
- Published in:
- PLoS ONE, 2009, v. 4, n. 6, p. 1, doi. 10.1371/journal.pone.0005934
- By:
- Publication type:
- Article
MVA.85A Boosting of BCG and an Attenuated, phoP Deficient M. tuberculosis Vaccine Both Show Protective Efficacy Against Tuberculosis in Rhesus Macaques.
- Published in:
- PLoS ONE, 2009, v. 4, n. 4, p. 1, doi. 10.1371/journal.pone.0005264
- By:
- Publication type:
- Article
Safety and Immunogenicity of the Candidate Tuberculosis Vaccine MVA85A in West Africa.
- Published in:
- PLoS ONE, 2008, v. 3, n. 8, p. 1, doi. 10.1371/journal.pone.0002921
- By:
- Publication type:
- Article
Immunological Outcomes of New Tuberculosis Vaccine Trials: WHO Panel Recommendations.
- Published in:
- PLoS Medicine, 2008, v. 5, n. 7, p. e145, doi. 10.1371/journal.pmed.0050145
- By:
- Publication type:
- Article
The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays.
- Published in:
- Scientific Reports, 2017, p. 43478, doi. 10.1038/srep43478
- By:
- Publication type:
- Article
Immunogenicity of the Tuberculosis Vaccine MVA85A Is Reduced by Coadministration with EPI Vaccines in a Randomized Controlled Trial in Gambian Infants.
- Published in:
- Science Translational Medicine, 2011, v. 3, n. 88, p. 1, doi. 10.1126/scitranslmed.3002461
- By:
- Publication type:
- Article
Markers of achievement for assessing and monitoring gender equity in a UK National Institute for Health Research Biomedical Research Centre: A two-factor model.
- Published in:
- PLoS ONE, 2020, p. 1, doi. 10.1371/journal.pone.0239589
- By:
- Publication type:
- Article
Towards new TB vaccines.
- Published in:
- Seminars in Immunopathology, 2020, v. 42, n. 3, p. 315, doi. 10.1007/s00281-020-00794-0
- By:
- Publication type:
- Article
Controlled Human Infection Models: Is it Really Feasible to Give People Tuberculosis?
- Published in:
- 2020
- By:
- Publication type:
- editorial
Inflammatory and myeloid-associated gene expression before and one day after infant vaccination with MVA85A correlates with induction of a T cell response.
- Published in:
- BMC Infectious Diseases, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2334-14-314
- By:
- Publication type:
- Article
Inflammatory and myeloid-associated gene expression before and one day after infant vaccination with MVA85A correlates with induction of a T cell response.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Serum indoleamine 2,3-dioxygenase activity is associated with reduced immunogenicity following vaccination with MVA85A.
- Published in:
- 2014
- By:
- Publication type:
- journal article